Stay updated on Teclistamab Maintenance Combo vs Monotherapy Clinical Trial
Sign up to get notified when there's something new on the Teclistamab Maintenance Combo vs Monotherapy Clinical Trial page.

Latest updates to the Teclistamab Maintenance Combo vs Monotherapy Clinical Trial page
- Check5 days agoChange DetectedThe record history on 2025-12-30 includes updates to Contacts/Locations and Study Status (version 17, with a 2025-12-29 date), and a deletion occurred on 2025-12-08.SummaryDifference0.4%

- Check12 days agoChange DetectedRevision: v3.3.3 was added to the page history. The HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedEuropean Myeloma Network B.V. was added as sponsor/collaborator and the corresponding Contacts/Locations and Study Status sections were updated; Stichting European Myeloma Network and the former designation European Myeloma Network B.V. (Stichting European Myeloma Network) were removed.SummaryDifference0.7%

- Check41 days agoChange DetectedThe Record History now shows a new revision v3.3.2 and removes the previous v3.2.0 entry. This is a metadata update to the page history rather than changing trial data.SummaryDifference0.1%

- Check48 days agoChange DetectedThe funding/operating status notice banner at the top of the page was removed.SummaryDifference0.6%

- Check63 days agoChange DetectedNew screenshot shows minor updates to the Record History page, including added IPDSharing entries and small changes to Study Status/Contacts details. These alterations do not affect the core study data or the page's primary purpose.SummaryDifference0.1%

Stay in the know with updates to Teclistamab Maintenance Combo vs Monotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teclistamab Maintenance Combo vs Monotherapy Clinical Trial page.